Emrelis Prices, Coupons, Copay Cards & Patient Assistance
Emrelis (telisotuzumab vedotin) is a member of the miscellaneous antineoplastics drug class and is commonly used for Non Small Cell Lung Cancer.
Emrelis prices
Intravenous Powder For Injection
tllv 20 mg Emrelis intravenous powder for injection from $2,739.03 for 1 powder for injection
| Quantity | Per unit | Price |
|---|---|---|
| 1 | $2,739.03 | $2,739.03 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
tllv 100 mg Emrelis intravenous powder for injection from $13,663.56 for 1 powder for injection
| Quantity | Per unit | Price |
|---|---|---|
| 1 | $13,663.56 | $13,663.56 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Get your FREE Drugs.com Discount Card
Save up to 80% off the cost of prescription drugs and OTC medicines valid at over 65,000 pharmacies.
This is a drug discount program, not an insurance plan.
Emrelis Coupons, Copay Cards and Rebates
Emrelis offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Emrelis Savings Card Program
Eligible commercially insured patients may pay as little $0 per prescription with savings of up to $25,000 per calendar year.
- Applies to:
- Emrelis
- Number of uses:
- Per calendar year
Form more information phone: 844-859-5760 or Visit website
Patient Assistance & Copay Programs for Emrelis
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: myAbbVie Assist for Emrelis
Eligibility requirements:- Must be uninsured or underinsured
- At or below 400% of FPL
- Not applicable
- Must reside in the US and be under the direct care of a US physician
- Any patient who requires the medication and are in need should call the company. Eligibility determined on a case-by-case basis. Patients with prescription drug coverage may be eligible on exception basis. Contact program for details.
- Emrelis (telisotuzumab vedotin-tllv) Injection; IV
More information please phone: 844-900-2228 Visit website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
See also:
More about Emrelis (telisotuzumab vedotin)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antineoplastics
- En español